Suppr超能文献

母亲美沙酮给药方案与胎儿神经行为

Maternal methadone dosing schedule and fetal neurobehaviour.

作者信息

Jansson Lauren M, Dipietro Janet A, Velez Martha, Elko Andrea, Knauer Heather, Kivlighan Katie T

机构信息

Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

出版信息

J Matern Fetal Neonatal Med. 2009 Jan;22(1):29-35. doi: 10.1080/14767050802452291.

Abstract

OBJECTIVE

Daily methadone maintenance is the standard of care for opiate dependency during pregnancy. Previous research has indicated that single-dose maternal methadone administration significantly suppresses fetal neurobehaviours. The purpose of this study was to determine if split-dosing would have less impact on fetal neurobehaviour than single-dose administration.

METHODS

Forty methadone-maintained women were evaluated at peak and trough maternal methadone levels on single- and split-dosing schedules. Monitoring sessions occurred at 36- and 37-weeks gestation in a counterbalanced study design. Fetal measures included heart rate, variability, accelerations, motor activity and fetal movement-heart rate coupling (FM-FHR). Maternal measures included heart period, variability, skin conductance, respiration and vagal tone. Repeated measure analysis of variance was used to evaluate within-subject changes between split- and single-dosing regimens.

RESULTS

All fetal neurobehavioural parameters were suppressed by maternal methadone administration, regardless of dosing regimen. Fetal parameters at peak were significantly lower during single versus split methadone administration. FM-FHR coupling was less suppressed from trough to peak during split-dosing versus single-dosing. Maternal physiologic parameters were generally unaffected by dosing condition.

CONCLUSION

Split-dosed fetuses displayed less neurobehavioural suppression from trough to peak maternal methadone levels as compared with single-dosed fetuses. Split-dosing may be beneficial for methadone-maintained pregnant women.

摘要

目的

每日美沙酮维持治疗是孕期阿片类药物依赖的标准治疗方法。先前的研究表明,单次给予母体美沙酮会显著抑制胎儿神经行为。本研究的目的是确定分次给药对胎儿神经行为的影响是否小于单次给药。

方法

40名接受美沙酮维持治疗的女性在单次给药和分次给药方案下,于母体美沙酮血药浓度峰值和谷值时接受评估。在一项平衡研究设计中,于妊娠36周和37周进行监测。胎儿测量指标包括心率、变异性、加速、运动活动以及胎儿运动-心率耦合(FM-FHR)。母体测量指标包括心动周期、变异性、皮肤电导、呼吸和迷走神经张力。采用重复测量方差分析来评估分次给药和单次给药方案之间的受试者内变化。

结果

无论给药方案如何,母体美沙酮给药均会抑制所有胎儿神经行为参数。与分次给药相比,单次美沙酮给药时峰值处的胎儿参数显著更低。与单次给药相比,分次给药时从谷值到峰值FM-FHR耦合受抑制程度更小。母体生理参数一般不受给药条件影响。

结论

与单次给药的胎儿相比,分次给药的胎儿在母体美沙酮血药浓度从谷值到峰值时神经行为受抑制程度更小。分次给药可能对接受美沙酮维持治疗的孕妇有益。

相似文献

1
Maternal methadone dosing schedule and fetal neurobehaviour.
J Matern Fetal Neonatal Med. 2009 Jan;22(1):29-35. doi: 10.1080/14767050802452291.
2
Fetal neurobehavioral effects of exposure to methadone or buprenorphine.
Neurotoxicol Teratol. 2011 Mar-Apr;33(2):240-3. doi: 10.1016/j.ntt.2010.09.003. Epub 2010 Sep 22.
3
Fetal assessment before and after dosing with buprenorphine or methadone.
Addiction. 2012 Nov;107 Suppl 1(0 1):36-44. doi: 10.1111/j.1360-0443.2012.04037.x.
4
Fetal response to maternal methadone administration.
Am J Obstet Gynecol. 2005 Sep;193(3 Pt 1):611-7. doi: 10.1016/j.ajog.2005.02.075.
6
Maternal buprenorphine treatment and fetal neurobehavioral development.
Am J Obstet Gynecol. 2017 May;216(5):529.e1-529.e8. doi: 10.1016/j.ajog.2017.01.040. Epub 2017 Feb 7.
7
Effect of chronic maternal methadone therapy on intrapartum fetal heart rate patterns.
J Soc Gynecol Investig. 2006 Feb;13(2):108-11. doi: 10.1016/j.jsgi.2005.11.001.
8
The effect of methadone treatment on the quantity and quality of human fetal movement.
Neurotoxicol Teratol. 2004 Jan-Feb;26(1):23-34. doi: 10.1016/j.ntt.2003.09.003.
10
Methadone dosing and pregnancy: impact on program compliance.
Int J Addict. 1995 Jan;30(2):207-17. doi: 10.3109/10826089509060743.

引用本文的文献

1
Neonatal Neurobehavior Predicts Neonatal Opioid Withdrawal Syndrome Severity Prior to Treatment Interventions.
J Pediatr. 2025 Jun;281:114533. doi: 10.1016/j.jpeds.2025.114533. Epub 2025 Mar 11.
2
3
Opioid, methamphetamine, and polysubstance use: perinatal outcomes for the mother and infant.
Front Pediatr. 2023 Dec 18;11:1305508. doi: 10.3389/fped.2023.1305508. eCollection 2023.
4
Methadone and neonatal abstinence syndrome (NAS): what we think we know, but do not.
Front Pediatr. 2023 Dec 21;11:1316583. doi: 10.3389/fped.2023.1316583. eCollection 2023.
5
Neonatal Abstinence Syndrome in Infants with Prenatal Exposure to Methadone versus Buprenorphine.
Children (Basel). 2023 Jun 8;10(6):1030. doi: 10.3390/children10061030.
6
Opioid use disorder in pregnancy.
Ment Health Clin. 2019 Nov 27;9(6):359-372. doi: 10.9740/mhc.2019.11.359. eCollection 2019 Nov.
7
Opioid Use in Pregnancy.
Curr Psychiatry Rep. 2019 Nov 16;21(12):118. doi: 10.1007/s11920-019-1110-4.
8
Early life stress and environmental influences on the neurodevelopment of children with prenatal opioid exposure.
Neurobiol Stress. 2018 Aug 15;9:48-54. doi: 10.1016/j.ynstr.2018.08.005. eCollection 2018 Nov.
9
Antenatal interventions based upon fetal surveillance of the daily opioid-exposed fetus: a descriptive analysis.
J Matern Fetal Neonatal Med. 2020 Mar;33(6):909-912. doi: 10.1080/14767058.2018.1509067. Epub 2018 Sep 10.
10
Prenatal methadone exposure is associated with altered neonatal brain development.
Neuroimage Clin. 2017 Dec 24;18:9-14. doi: 10.1016/j.nicl.2017.12.033. eCollection 2018.

本文引用的文献

2
Concentrations of methadone in breast milk and plasma in the immediate perinatal period.
J Hum Lact. 2007 May;23(2):184-90. doi: 10.1177/0890334407300336.
3
Changes to methadone clearance during pregnancy.
Eur J Clin Pharmacol. 2005 Nov;61(10):763-8. doi: 10.1007/s00228-005-0035-5. Epub 2005 Oct 29.
4
Fetal response to maternal methadone administration.
Am J Obstet Gynecol. 2005 Sep;193(3 Pt 1):611-7. doi: 10.1016/j.ajog.2005.02.075.
5
High-dose methadone maintenance in pregnancy: maternal and neonatal outcomes.
Am J Obstet Gynecol. 2005 Sep;193(3 Pt 1):606-10. doi: 10.1016/j.ajog.2005.03.072.
6
The effect of methadone treatment on the quantity and quality of human fetal movement.
Neurotoxicol Teratol. 2004 Jan-Feb;26(1):23-34. doi: 10.1016/j.ntt.2003.09.003.
8
Alterations in methadone metabolism during late pregnancy.
J Addict Dis. 1999;18(4):51-61. doi: 10.1300/J069v18n04_05.
9
Fetal movement detection: comparison of the Toitu actograph with ultrasound from 20 weeks gestation.
J Matern Fetal Med. 1999 Nov-Dec;8(6):237-42. doi: 10.1002/(SICI)1520-6661(199911/12)8:6<237::AID-MFM1>3.0.CO;2-F.
10
Opioid dependence during pregnancy. Effects and management.
Obstet Gynecol Clin North Am. 1998 Mar;25(1):139-51. doi: 10.1016/s0889-8545(05)70362-4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验